Deniz B, Brogan AJ, Miller JD, Talbird SE, Thompson J. Cost-effectiveness assessment of telaprevir combination treatment compared to pegylated-interferon + ribavirin alone in the management of chronic hepatitis C in patients who failed a prior pegylated-interferon + ribavirin treatment. Poster presented at the Annual Scientific Meeting of the American College of Gastroenterology; October 2011.
Brogan AJ, Miller JD, Talbird SE, Thompson J, Deniz B. Long-term clinical value of telaprevir for treatment of treatment-naïve and treatment-experienced patients with hepatitis C virus infection: projections using decision-analytic modeling. Poster presented at the 2011 Digestive Disease Week; May 9, 2011. Chicago, IL.